Pub. Date : 2021 Jan 1
PMID : 33212505
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
1 | Does metformin improve the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor treatment for patients with advanced non-small-cell lung cancer? | Metformin | epidermal growth factor receptor | Homo sapiens |
2 | The question addressed was whether metformin improved the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment for patients with epidermal growth factor receptor (EGFR)-mutated advanced non-small-cell lung cancer. | Metformin | epidermal growth factor receptor | Homo sapiens |
3 | The question addressed was whether metformin improved the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment for patients with epidermal growth factor receptor (EGFR)-mutated advanced non-small-cell lung cancer. | Metformin | epidermal growth factor receptor | Homo sapiens |
4 | The question addressed was whether metformin improved the efficacy of standard epidermal growth factor receptor-tyrosine kinase inhibitor (EGFR-TKI) treatment for patients with epidermal growth factor receptor (EGFR)-mutated advanced non-small-cell lung cancer. | Metformin | epidermal growth factor receptor | Homo sapiens |
5 | We concluded that the addition of metformin to EGFR-TKI might improve the survival of patients with EGFR-mutated non-small-cell lung cancer and diabetes mellitus type 2. | Metformin | epidermal growth factor receptor | Homo sapiens |
6 | However, for non-diabetic non-small-cell lung cancer patients with EGFR mutation, the efficiency of additional metformin in EGFR-TKI treatment remains unclear because of the conflicting results of only 2 available studies. | Metformin | epidermal growth factor receptor | Homo sapiens |